Sonoma Pharmaceuticals SNOA Slips 356 Testing 108 Support 20260515 Accuray ARAY Slides 520 as Selling Pressure Mounts 20260515 US Job Openings Drop to 14Month Low as Hiring Weakens Latest Data Shows Analysts Identify Top SmallCap Biotech Stocks with Growth Potential Could SpaceX Become the Least ShareholderFriendly Public Company Ever Australia Shares Dip as SPASX 200 Closes Lower by 039 SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms Companies Push Ahead with Prediction Market Investments Amid Regulatory Uncertainty MM Packaging Deeside Names Dave Whitworth as New Managing Director Trainline Lifts Guidance Again Amid Strong Rail Ticket Sales BDTX Q1 2026 Earnings NarrowerThanExpected Loss Fails to Offset Market Concerns Sachem Capital SACH Q4 2025 Earnings EPS Surges 782 Above Estimates Shares Decline Despite Strong Bottom Line WEC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Tao Synergies Inc TAOX Q4 2024 Earnings EPS Misses Estimates as Shares Slide CME Group Q1 2026 Earnings Earnings Miss Estimates as EPS Falls Short VRME Q4 2025 Earnings EPS Misses Estimates Amidst Challenging Quarter Eagle Point Credit Co Notes ECCX Hold Steady Near 25 as Bond Market Awaits Clarity PDF Solutions Surges 339 as Shares Approach Key Resistance Level Eaton Vance Enhanced Equity Income Fund II EOS Hovers Near Support Amid Low Volatility Prenetics Global PRE Surges 31 Approaching Key Resistance Near 1815 JX Luxventure Group Inc JXG Surges 695 Approaching Key Resistance Weather Derivatives Set to Begin Trading on May 29 CLMT Q1 2026 Earnings Staggering EPS Miss Overshadowed by Positive Stock Movement ACV Auctions ACVA Holds Steady Near Support as Market Awaits Direction FRHC Q1 2026 Earnings EPS of 125 Surprises Shares Slip 323 BAER Q1 2026 Earnings Wide EPS Miss Overshadowed by Positive Stock Movement TRVI Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Development Stage RCUS Q1 2026 Earnings WiderthanExpected Loss Highlights Ongoing Biotech Development Costs Cytokinetics Q1 2026 Earnings Narrower Loss Beats Estimates as Lead Program Aficamten Advances NXPI Q1 2026 Earnings EPS Tops Estimates Amid Resilient Demand SHFS Q3 2024 Earnings Profitability Achieved Despite Limited Disclosure